An immunocytochemical assessment of 19 cases of cutaneous angiosarcoma.
Four endothelial cell markers, two selective cytokeratin markers and a monoclonal smooth muscle antibody (SMA) were employed in the assessment of 19 cases of cutaneous angiosarcoma classified according to their degree of tumour differentiation. No labelling was seen for SMA or with cytokeratin markers MNF116 and CBL170. Expression of factor VIII-related antigen was seen in two tumours and positivity for CD34 (QBend 10 antibody) was found in four tumours. By contrast the pan-endothelial cell marker Ulex europeaus agglutinin 1 (UEA-1) and the CD31 marker JC70A labelled all cases of cutaneous angiosarcoma with the exception of one poorly differentiated tumour. These data confirm the endothelial cell origin of angiosarcoma, they demonstrate that CD31 and UEA1 are reliable markers in routinely processed tissue, and they suggest a lymphatic derivation for the tumour. This finding is in marked contrast to Kaposi's sarcoma where CD34 is the most reliable marker.
Orchard
G E
GE
Department of Dermatopathology, St John's Dermatology Centre, St Thomas' Hospital, London, UK.
Zelger
B
B
Jones
E W
EW
Jones
R R
RR
D000911:Antibodies, Monoclonal; D006394:Hemangiosarcoma / Q000737:chemistry* / Q000276:immunology / Q000473:pathology*; D006801:Humans; D007150:Immunohistochemistry; D012878:Skin Neoplasms / Q000737:chemistry* / Q000276:immunology / Q000473:pathology*
D000911:Antibodies, Monoclonal